This patent teaches how to differentiate hematopoietic stem cells into a type of stem cell that is committed to the neutrophil lineage. These "committed" stem cells may be administered into a neutropenic patient until endogenous neutrophils rebound.
View this patent on the USPTO website.
 
  
  
  
  
  
  
  
  
  
  
       
    Add Comment
 Add CommentYou must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.